MUMBAI, June 29 (Reuters) - Drugmaker Alembic Ltd said on Tuesday its board approved the demerger of its core pharmaceuticals business into a separate unit, paving the way for the company's entry into ...

Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated urinary tract infections PIVYA expected to be available in the U.S. in the 4th ...

Feb 12, 2026, 11:01 PM IST Alembic - Standalone And Consolidated Financial Results For The Quarter And Nine Months Period Ended 31St December, 2025 Feb 12, 2026, 10:55 PM IST Alembic - Board Meeting ...

ALEMBIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2024 inter alia to consider and approve Unaudited Financial Results of the Company for the ...

Alembic Pharma announces first prescription sale of Pivya following US commercial launch: Our Bureau, Mumbai Friday, March 6, 2026, 16:30 Hrs [IST] Alembic Pharmaceuticals Limited ...

Shares of Alembic Pharmaceuticals Ltd (APL) on Thursday surged over 8 per cent after the company entered into a joint venture with Orbicular Pharmaceutical to develop, manufacture and commercialise ...

Alembic Pharmaceuticals Expands into Thailand 🇹🇭 | MCap 14,328.47 Cr • Incorporated new subsidiary: Alembic Pharmaceuticals (Thailand) Co., Ltd. • Initial share capital: 3,000,000 Thai Baht (300,000 ...

MUMBAI, Feb 1 (Reuters) - Drug maker Alembic Ltd. said on Thursday it would buy Dabur Pharma Ltd.'s non-oncology drugs unit for 1.59 billion rupees, to gain strategic entry into the high-growth, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...